Search Results - "Zbrozek, Arthur S."

Fiscal Implications of Newborn Screening in the Diagnosis of Severe Combined Immunodeficiency by Kubiak, Catherine, MD, Jyonouchi, Soma, MD, Kuo, Caroline, MD, Garcia-Lloret, Maria, MD, Dorsey, Morna J., MD, MMSc, Sleasman, John, MD, Zbrozek, Arthur S., RPh, MSc, MBA, Perez, Elena E., MD, PhD

“…In the United States, newborn screening (NBS) is currently recommended for identification of 31 debilitating and potentially fatal conditions. However,…”
Get full text

The economic burden of Medicare-eligible patients by multiple sclerosis type by Gilden, Daniel M., MS, Kubisiak, Joanna, MPH, Zbrozek, Arthur S., MS, MBA

“…Abstract Objective Although the global rate of multiple sclerosis (MS) is low, a few studies have documented high costs. Costs are highly variable depending on…”
Get full text

The validity and reproducibility of a work productivity and activity impairment instrument by Reilly, M C, Zbrozek, A S, Dukes, E M

“…The construct validity of a quantitative work productivity and activity impairment (WPAI) measure of health outcomes was tested for use in clinical trials,…”
Get full text

Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada by Gerth, William C, Betschel, Stephen D, Zbrozek, Arthur S

“…Switching primary/secondary immunodeficiency (PID/SID) patients from intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy…”
Get full text

Q-TWiST Analysis of Patients Receiving Temsirolimus or Interferon Alpha for Treatment of Advanced Renal Cell Carcinoma by Zbrozek, Arthur S., Hudes, Gary, Levy, Donna, Strahs, Andrew, Berkenblit, Anna, De Marinis, Robert, Parasuraman, Shreekant

“…Background and Objective : For patients with advanced cancers, it is important that treatment improves the quality as well as the quantity of survival. This…”
Get full text

Willingness-to-pay for reductions in care need: estimating the value of informal care in Alzheimer's disease by Gustavsson, Anders, Jönsson, Linus, McShane, Rupert, Boada, Mercè, Wimo, Anders, Zbrozek, Arthur S.

“…Objective To estimate the value of informal care in Alzheimer's disease using contingent valuation. Methods A questionnaire was administered to 517 primary…”
Get full text

Patient dependence and longitudinal changes in costs of care in Alzheimer's disease by Zhu, Carolyn W, Leibman, Christopher, McLaughlin, Trent, Zbrozek, Arthur S, Scarmeas, Nikolaos, Albert, Marilyn, Brandt, Jason, Blacker, Deborah, Sano, Mary, Stern, Yaakov

“…To examine the incremental effect of patients' dependence on others, on cost of medical and nonmedical care, and on informal caregiving hours over time. Data…”
Get more information

Estimation and Validation of a Multiattribute Model of Alzheimer Disease Progression by Stallard, Eric, Kinosian, Bruce, Zbrozek, Arthur S., Yashin, Anatoliy I., Glick, Henry A., Stern, Yaakov

“…Objectives. To estimate and validate a multiattribute model of the clinical course of Alzheimer disease (AD) from mild AD to death in a high-quality…”
Get full text

Baseline Differences and Trajectories of Change for Deceased, Placed, and Community Residing Alzheimer Disease Patients by SCHULZ, Richard, ZDANIUK, Bozena, BELLE, Steven H, CZAJA, Sara J, ARRIGHI, Henry Michael, ZBROZEK, Arthur S

“…This study identifies predictors of placement or death in a large ethnically/racially diverse sample of moderately impaired Alzheimer disease patients residing…”
Get full text

P3-476: Willingness to pay for reductions in care need: Estimating the value of informal care by Gustavsson, Anders, Jönsson, Linus, Zbrozek, Arthur S

Get full text

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia by EASTMAN, R. C, JAVITT, J. C, GARFIELD, S. A, HARRIS, M, HERMAN, W. H, DASBACH, E. J, COPLEY-MERRIMAN, C, MAIER, W, DONG, F, MANNINEN, D, ZBROZEK, A. S, KOTSANOS, J

“…Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. R C Eastman , J C…”
Get full text

Model of complications of NIDDM. I. Model construction and assumptions by EASTMAN, R. C, JAVITT, J. C, EASTMAN, J. E, KOTSANOS, J, COWIE, C. C, HARRIS, M, HERMAN, W. H, DASBACH, E. J, ZBROZEK, A. S, DONG, F, MANNINEN, D, GARFIELD, S. A, COPLEY-MERRIMAN, C, MAIER, W

“…Model of complications of NIDDM. I. Model construction and assumptions. R C Eastman , J C Javitt , W H Herman , E J Dasbach , A S Zbrozek , F Dong , D Manninen…”
Get full text

P3-049: Estimating the cost offsets to U.S. medicare budgets from the hypothetical slowing of Alzheimer's disease progression by Stallard, Eric, Kinosian, Bruce, Zbrozek, Arthur S, Yashin, Anatoliy I, Stern, Yaakov

Get full text

P3-464: The association between changes in dementia patient functioning and changes in caregiver outcomes by Czaja, Sara J, Schulz, Richard, Zdaniuk, Bozena, Belle, Steven, Arrighi, H. Michael, Zbrozek, Arthur S

Get full text

O3-07-02: Baseline differences and trajectories of change for patient-caregiver dyads in the Resources for Enhancing Alzheimer's Caregiver Health (REACH) study differentiated by end-of-study patient outcome by Schulz, Richard, Zdaniuk, Bozena, Czaja, Sara J, Belle, Steven, Arrighi, H. Michael, Zbrozek, Arthur S

Get full text

Development and Testing of a New Outcome Measure of Relationship Between Patients With Alzheimer's Disease and Their Partners by Reilly, Margaret C., Relkin, Norman R., Zbrozek, Arthur S.

“…In mild Alzheimer's disease (AD), loss of relationship with the patient is a significant consequence for the partner (relative) and may be amenable to…”
Get full text

Assessing the responsiveness of a quality-of-life instrument and the measurement of symptom severity in essential hypertension by Reilly, M C, Zbrozek, A S

“…A pilot study was conducted to compare symptoms elicited with an open-ended question versus a checklist and to measure the responsiveness of quality-of-life…”
Get full text

Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada by Gerth, William C, Betschel, Stephen D, Zbrozek, Arthur S

Get full text

P-148: The resource utilization in dementia (RUD) instrument is valid to assess informal care time in dementia by Wimo, Anders, Jönsson, Linus, Zbrozek, Arthur S.

Get full text

Rifabutin Prophylaxis against Mycobacterium avium Complex Infection by Goldschmidt, R H, Hearst, N, Chambers, D B

“…To the Editor: The article on rifabutin prophylaxis against Mycobacterium avium complex disease by Nightingale et al. (Sept. 16 issue) 1 provides important…”
Get full text